Farmed Cattle Feed Additives and Welfare Implications

Feed additives including beta-agonists used to promote rapid muscle growth in beef cattle can cause welfare problems including lameness and cardiovascular stress in treated animals.

Key Facts

Zilpaterol hydrochloride (Zilmax) and ractopamine are beta-agonist feed additives used in US beef finishing
Both compounds promote rapid lean muscle accretion in the final weeks before slaughter
Zilmax was voluntarily withdrawn from the US market in 2013 after videos showed cattle with severe mobility problems
Ractopamine remains approved in the US and several other countries but is banned in the EU, China, and others
Beta-agonist treated cattle show elevated rates of dark-cutting meat, a stress indicator, and cardiac changes

Welfare Considerations

Beta-agonist feed additives illustrate how production tools developed to enhance efficiency can generate welfare problems in animals already at the physiological limits of their design. Rapid muscle growth driven by these compounds occurs faster than skeletal and cardiovascular systems can adapt, producing lameness, difficulty rising, and evidence of cardiac stress. The withdrawal of Zilmax after welfare problems became publicly documented represents market pressure correcting a regulatory failure. The continued use of ractopamine in some jurisdictions, despite its ban in others, reflects ongoing regulatory inconsistency around a compound with documented welfare concerns.

What You Can Do

Choose beef certified as beta-agonist free where such labeling exists
Support campaigns for ractopamine prohibition in countries where it remains approved
Advocate for comprehensive pre-slaughter mobility scoring that creates accountability for lameness-causing additives
Reduce beef consumption to lower demand on production systems using welfare-compromising growth enhancers